From: Transcriptional reprogramming of metabolic pathways in critically ill patients
Ā | Sepsis | SIRS | Healthy controls |
---|---|---|---|
Demographics | Ā | Ā | Ā |
āNumber in group | 35 | 12 | 18 |
āMean age (year) | 64 | 61 | 43 |
Severity of illness | Ā | Ā | Ā |
āMortality (%) | 26 | 0 | 0 |
āMean APACHE II | 20 | 16 | NA |
āVasopressor support (%) | 72 | 16.8 | 0 |
āRenal support (dialysis) (%) | 26 | 8.3 | 0 |
āMechanical ventilation (%) | 78 | 75 | 0 |
Presentation (n)a | Ā | Ā | Ā |
āPulmonary infection | 17 | 0 | 0 |
āUrinary tract infection | 4 | 0 | 0 |
āAbdominal sepsis | 6 | 0 | 0 |
āSepticaemia | 3 | 0 | 0 |
āSoft tissue infection | 3 | 0 | 0 |
āInfective endocarditis | 2 | 0 | 0 |
āPost emergency surgery | 7 | 1 | 0 |
āTrauma | 1 | 1 | 0 |
āMyocardial infarction | 0 | 3 | 0 |
āSevere pancreatitis | 0 | 1 | 0 |
āAcute pulmonary oedema | 0 | 2 | 0 |
āAcute haemorrhage | 0 | 2 | 0 |
āLiver failure | 0 | 1 | 0 |
āCardiogenic shock | 0 | 2 | 0 |
āArrhythmias | 0 | 2 | 0 |
āCerebral infarction | 0 | 2 | 0 |
Pre-existing illness (n)a | Ā | Ā | Ā |
āHypertension | 9 | 7 | 3 |
āIschaemic heart disease | 9 | 4 | 0 |
āChronic lung disease | 8 | 2 | 0 |
āCancer | 6 | 0 | 0 |
āDiabetes | 7 | 3 | 0 |